<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>phages on Mycobacterial Infection Research Unit</title>
    <link>https://miru-ffm.org/tags/phages/</link>
    <description>Recent content in phages on Mycobacterial Infection Research Unit</description>
    <generator>Source Themes academia (https://sourcethemes.com/academic/)</generator>
    <language>en-us</language>
    <copyright>Copyright &amp;copy; {year}</copyright>
    <lastBuildDate>Mon, 01 Jun 2026 00:00:00 +0000</lastBuildDate>
    
	    <atom:link href="https://miru-ffm.org/tags/phages/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>Review on mycobacteriophage therapy for NTM infections published</title>
      <link>https://miru-ffm.org/news/post13/</link>
      <pubDate>Mon, 01 Jun 2026 00:00:00 +0000</pubDate>
      
      <guid>https://miru-ffm.org/news/post13/</guid>
      <description>&lt;p&gt;Non-tuberculous mycobacteria (NTM) can present a serious clinical threat due to their resistance to conventional antibiotics and their ability to cause persistent infections. Mycobacteriophages (MPs) are emerging as a promising therapeutic addition or alternative.
&lt;br&gt;&lt;br&gt;
This review explores the biological characteristics, therapeutic mechanisms, and clinical potential of MPs. Based on data from in vitro studies, animal models, and human compassionate-use cases, we highlight the mycobactericidal efficacy of MPs as well as their potential to complement antibiotic treatment regimens.
&lt;br&gt;&lt;br&gt;
You can find the full publication via the &lt;a href=&#34;https://link.springer.com/article/10.1007/s15010-026-02818-7&#34;&gt;journal&amp;rsquo;s homepage&lt;/a&gt;, &lt;a href=&#34;https://pubmed.ncbi.nlm.nih.gov/42223842/&#34;&gt;PubMed&lt;/a&gt;  or the &lt;a href=&#34;https://miru-ffm.org/publication/infection_2026&#34;&gt;MIRU website&lt;/a&gt;.&lt;/p&gt;
</description>
    </item>
    
  </channel>
</rss>
